avanti polar lipids/18:1 Biotinyl PE/25mg/870282P-25mg,avanti polar lipids,,Avanti Polar,Avanti,avantilipids,Avanti Polar Lipids Inc,Avanti Polar Lipids公司 Avanti Polar Lipids甾体类,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：avanti polar lipids/18:1 Biotinyl PE/25mg/870282P-25mg

产品编号：870282P-25mg

市场价：¥3415.00

场地：美国(厂家直采)

产品分类：生化试剂>其他>酯>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$170.75

品牌： avanti polar lipids

公司：Avanti Lipids Polar, Inc.

公司分类：

商品介绍

870282 | 18:1 Biotinyl PE

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt)

Info

18:1 Biotinyl PE

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt)

Data

Hygroscopic

Yes

Light Sensitive

Molecular Formula

C₅₁H₉₁N₃O₁₀PNaS

Percent Composition

C 61.73%, H 9.24%, N 4.23%, Na 2.32%, O 16.12%, P 3.12%, S 3.23%

Purity

>99%

Stability

1 Year

Storage Temperature

-20°C

CAS Number

384835-53-4 CAS Registry Number is a Registered Trademark of the American Chemical Society

FormulaWeight

992.311

Exact Mass

991.606

Synonyms

1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine-N-(biotinyl) (sodium salt)

Downloads

ChemDraw File
3D Structure
Structure
Safety Data Sheet

References

Ventura AE, Varela ARP, Dingjan T, Santos TCB, Fedorov A, Futerman AH, Prieto M, Silva LC. Lipid domain formation and membrane shaping by C24-ceramide. Biochim Biophys Acta Biomembr. 2020 Jun 18;1862(10):183400. doi: 10.1016/j.bbamem.2020.183400. Epub ahead of print. PMID: 32565121.

PubMed ID: 32565121

Imam ZI, Bachand GD. Multicomponent and Multiphase Lipid Nanotubes Formed by Gliding Microtubule-Kinesin Motility and Phase-Separated Giant Unilamellar Vesicles. Langmuir. 2019 Dec 10;35(49):16281-16289. doi: 10.1021/acs.langmuir.9b02637. Epub 2019 Nov 27.

PubMed ID: 31730350

Albertsson I, Sjöholm J, Ter Beek J, Watmough NJ, Widengren J, Ädelroth P. Functional interactions between nitrite reductase and nitric oxide reductase from Paracoccus denitrificans. Sci Rep. 2019 Nov 21;9(1):17234. doi: 10.1038/s41598-019-53553-z.

PubMed ID: 31754148

Glazier R, Brockman JM, Bartle E, Mattheyses AL, Destaing O, Salaita K. DNA mechanotechnology reveals that integrin receptors apply pN forces in podosomes on fluid substrates. Nat Commun. 2019 Oct 18;10(1):4507. doi: 10.1038/s41467-019-12304-4

PubMed ID: 31628308

Bao H, Goldschen-Ohm M, Jeggle P, Chanda B, Edwardson JM, Chapman ER. Exocytotic fusion pores are composed of both lipids and proteins. Nat Struct Mol Biol. 2016 Jan;23(1):67-73. doi: 10.1038/nsmb.3141. Epub 2015 Dec 14.

PubMed ID: 26656855

Bao H, Das D, Courtney NA, Jiang Y, Briguglio JS, Lou X, Roston D, Cui Q, Chanda B, Chapman ER. Dynamics and number of trans-SNARE complexes determine nascent fusion pore properties. Nature. 2018 Feb 8;554(7691):260-263. doi: 10.1038/nature25481. Epub 2018 Jan 31.

PubMed ID: 29420480

Wang M, Liu Z, Zhan W. Janus Liposomes: Gel-Assisted Formation and Bioaffinity-Directed Clustering. Langmuir. 2018 Jun 12. doi: 10.1021/acs.langmuir.8b00798. [Epub ahead of print]

PubMed ID: 29852065

Certificates of Analysis

Certificate of Analysis(Lot No. 870282C-100MG-A-036and 6179CLA036)
Certificate of Analysis(Lot No. 870282C-200MG-A-036and 6179CNA036)
Certificate of Analysis(Lot No. 870282C-25MG-A-036and 6179CJA036)
Certificate of Analysis(Lot No. 870282P-100MG-A-035and 6179PLA035)
Certificate of Analysis(Lot No. 870282P-200MG-A-035and 6179PNA035)
Certificate of Analysis(Lot No. 870282P-200MG-A-036and 6179PNA036)
Certificate of Analysis(Lot No. 870282P-25MG-A-035and 6179PJA035)
Certificate of Analysis(Lot No. 870282P-25MG-A-036and 6179PJA036)
Certificate of Analysis(Lot No. 870282C-25MG-B-036and 6179CJB036)
Certificate of Analysis(Lot No. 870282P-25MG-A-037and 6179PJA037)
Certificate of Analysis(Lot No. 870282C-25MG-A-037and 6179CJA037)
Certificate of Analysis(Lot No. 870282C-25MG-B-037and 6179CJB037)
Certificate of Analysis(Lot No. 870282P-25MG-B-037and 6179PJB037)
Certificate of Analysis(Lot No. 870282C-25MG-C-037and 6179CJC037)
Certificate of Analysis(Lot No. 870282P-25MG-D-037_6179PJD037and 6179PJD037)
Certificate of Analysis(Lot No. 870282C-25MG-D-037and 6179CJD037)
Certificate of Analysis(Lot No. 870282C-25MG-E-037and 6179CJE037)
Certificate of Analysis(Lot No. 870282C-25MG-F-037and 6179CJF037)
Certificate of Analysis(Lot No. 870282C-25MG-A-038and 6179CJA038)
Certificate of Analysis(Lot No. 870282C-25MG-B-038and 6179CJB038)
Certificate of Analysis(Lot No. 870282P-25MG-B-038and 6179PJB038)
Certificate of Analysis(Lot No. 870282P-25MG-A-039and 6179PJA039)
Certificate of Analysis(Lot No. 870282C-25MG-D-038and 6179CJD038)
Certificate of Analysis(Lot No. 870282C-25MG-C-038and 6179CJC038)
Certificate of Analysis(Lot No. 870282C-25MG-A-039and 6179CJA039)
Certificate of Analysis(Lot No. 870282P-25MG-B-039and 6179PJB039)

Base Price:${originalprice|money}

Custom Packaging:(${concentration} @$4.00/ea. + $100)${custompackagingtotal|money}

Packaging:${concentration}

Item Total:${totalprice|money}

(Sales Tax may apply)

Please select an option above.

Selected Product${sku} - ${concentration}

品牌介绍

Avanti Polar Lipids.jpg

Avanti Polar Lipids公司是美国著名的磷脂类产品的生产商，该公司主要为各种制药厂和研究机构提供从毫克级到公斤级乃至吨级的磷脂类和甾体类中间体和试剂。为世界范围内的研究机构和制药公司提供 1000 种以上脂类产品，由于其产品的高纯度而享誉全球。40年来，Avanti Polar Lipids公司为世界各地的研究人员和制药公司提供脂类产品。公司的产品不仅范围日益扩大，其纯度之高也是无人能及。

Avanti Polar Lipids, Inc., has a long history of 50 years creating the highest purity lipids available. Our passion for high quality and unique products is only exceeded by our excellent reputation in the marketplace. Although we are known for our lipids, we are More than Lipids. We offer solutions for the entire product cycle…Research to Commercialization.

Avanti Polar Lipids公司的主要产品和服务包括：

（1）Research Products

Highest Purity Lipid Reagents

（2）cGMP Manufacturing

API & Contract Manufacturing

（3）Adjuvants

Immunotherapy & Vaccine Development

（4）Analytical Services

Lipid Analysis

（5）Lipidomics

Mass Spec Standards, Antibodies & Lipid Toolbox

（6）Formulations